Physician profile
Steve E Musick
NPI 1831176775
$21,944.37
in general payments reported to CMS, 2019-2025
43 companies · $3,435 in 2025
The $3,435 reported for 2025 was more than what 86% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,379 · 2020: $2,072 · 2021: $1,931 · 2022: $2,788 · 2023: $3,696 · 2024: $3,643 · 2025: $3,435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,408.84 |
| Education | $366.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,391.28 | 2019-2025 | |
| Merz North America, INC. | $1,993.21 | 2019-2020 | |
| Janssen Biotech, INC. | $1,838.04 | 2019-2025 | Tremfya, Stelara, Simponi |
| Sun Pharmaceutical Industries INC. | $1,471.59 | 2019-2025 | Ilumya, Winlevi, Odomzo |
| Novartis Pharmaceuticals Corporation | $1,423.16 | 2019-2025 | |
| Leo Pharma INC. | $1,136.60 | 2019-2025 | Adbry, Anzupgo |
| Amgen INC. | $1,134.24 | 2019-2025 | Otezla, Otezla |
| Lilly USA, LLC | $1,075.11 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Pfizer INC. | $1,035.09 | 2019-2025 | |
| Dermavant Sciences, INC. | $851.50 | 2022-2024 | Vtama |
| Incyte Corporation | $773.51 | 2021-2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $740.58 | 2019-2025 | Libtayo, Dupixent |
| E.R. Squibb & Sons, L.L.C. | $674.27 | 2022-2025 | Sotyktu |
| Ucb, INC. | $601.78 | 2019-2025 | Bimzelx, Cimzia |
| Genzyme Corporation | $549.33 | 2019-2025 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Musick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.